These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15212652)

  • 1. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients.
    Tang NL; Chow CC; Ko GT; Tai MH; Kwok R; Yao XQ; Cockram CS
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):109-12. PubMed ID: 15212652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation screening in Chinese hypokalemic periodic paralysis patients.
    Wang W; Jiang L; Ye L; Zhu N; Su T; Guan L; Li X; Ning G
    Mol Genet Metab; 2006 Apr; 87(4):359-63. PubMed ID: 16386935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis.
    Kung AW; Lau KS; Fong GC; Chan V
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1340-5. PubMed ID: 15001631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis.
    Dias Da Silva MR; Cerutti JM; Arnaldi LA; Maciel RM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4881-4. PubMed ID: 12414843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis.
    Vendrame F; Verrienti A; Parlapiano C; Filetti S; Dotta F; Morano S
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):218-20. PubMed ID: 18325191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis.
    Sternberg D; Tabti N; Fournier E; Hainque B; Fontaine B
    Neurology; 2003 Sep; 61(6):857-9. PubMed ID: 14504341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress on the searchs of pathogenesis of thyrotoxic periodic paralysis].
    Shishiba Y
    Nihon Rinsho; 2006 Dec; 64(12):2339-47. PubMed ID: 17154102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
    Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
    Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation.
    Jurkat-Rott K; Lehmann-Horn F
    Neurology; 2004 Mar; 62(6):1012-5. PubMed ID: 15037716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis.
    Dias da Silva MR; Cerutti JM; Tengan CH; Furuzawa GK; Vieira TC; Gabbai AA; Maciel RM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):367-75. PubMed ID: 11940049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis of thyrotoxic periodic paralysis: spot urine calcium to phosphate ratio.
    Lin SH; Chu P; Cheng CJ; Chu SJ; Hung YJ; Lin YF
    Crit Care Med; 2006 Dec; 34(12):2984-9. PubMed ID: 16971853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP).
    Soonthornpun S; Setasuban W; Thamprasit A
    Clin Endocrinol (Oxf); 2009 May; 70(5):794-7. PubMed ID: 18759868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thyrotoxic periodic paralysis].
    Hansen PS; Bonnema SJ; Hegedüs L
    Ugeskr Laeger; 1999 Aug; 161(31):4411-2. PubMed ID: 10487108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotoxic periodic paralysis and the sodium/potassium pump.
    Marx A; Ruppersberg JP; Pietrzyk C; Rüdel R
    Muscle Nerve; 1989 Oct; 12(10):810-5. PubMed ID: 2558311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise test on the patients with normokalaemic periodic paralysis from a Chinese family with a mutation in the SCN4A gene.
    Feng Y; Zhang Y; Liu ZL; Zhang CD
    Chin Med J (Engl); 2008 Oct; 121(19):1915-9. PubMed ID: 19080124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis.
    Ng WY; Lui KF; Thai AC; Cheah JS
    Thyroid; 2004 Mar; 14(3):187-90. PubMed ID: 15072700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A novel mutation of KCNQ2 gene in a Chinese family with benign familial neonatal convulsions].
    Li HY; Tang BS; Zhang AM; Cao QH; Meng GL; Jiang H; Shen L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):482-5. PubMed ID: 14669214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle membrane excitability after exercise in thyrotoxic periodic paralysis and thyrotoxicosis without periodic paralysis.
    Arimura K; Arimura Y; Ng AR; Sakoda S; Higuchi I
    Muscle Nerve; 2007 Dec; 36(6):784-8. PubMed ID: 17722048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening SCN4A gene for mutations with denaturing high performance liquid chromatography technology in a Chinese family with normokalemic periodic paralysis].
    Guo XH; Wu WP; Zhang YH; Wang HB; Mao YL; Zhu K
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):125-9. PubMed ID: 14990128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxic periodic paralysis admitted to the medical department in Qatar.
    Abbas MT; Khan FY; Errayes M; Baidaa AD; Haleem AH
    Neth J Med; 2008 Oct; 66(9):384-8. PubMed ID: 18931399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.